TORONTO – EasyMed Services Inc. (CNSX:EZM) says it has terminated a contract to join forces with Canadian device maker Biosign Technologies Inc. (TSXV:BIO) after Biosign failed to raise necessary financing conditions.
The Swiss company that specializes in medical databases and social networking for the health-care industry said the decision to end the contract to combine operations was mutually agreed and no payments are owed by either company.
Get weekly money news
It said Biosign failed to raise the minimum of $2 million in financing due to the “difficult economic climate.”
“We would like to point out however that the distribution agreement between our respective companies is still valid and after the Biosign restructuring we hope to engage in the future on viable business opportunities,” said EasyMed CEO Tejinder Sahota.
Under the cancelled agreement, shareholders of EasyMed would have ended up with two-thirds and Biosign shareholders would own one-third of the stock the new company.
The Toronto-based company creates biomedical systems that provide non-invasive monitoring of health risks associated with blood pressure, glucose and medication.
EasyMed provides database and software technology to enable organizations to deliver health-care services on mobile devices.
Comments
Want to discuss? Please read our Commenting Policy first.